A practical Guide to Treatment with Liraglutide
- Resource Type
- Authors
- Vassiliki Bravis; Devasenan Devendra
- Source
- Clinical Medicine Insights: Therapeutics, Vol 2 (2010)
- Subject
- Pharmacology
medicine.medical_specialty
Liraglutide
business.industry
lcsh:RM1-950
Pharmaceutical Science
General Medicine
Type 2 diabetes
Hypoglycemia
medicine.disease
Glimepiride
lcsh:Therapeutics. Pharmacology
Blood pressure
Diabetes mellitus
medicine
Intensive care medicine
business
Exenatide
Biomedical engineering
medicine.drug
Glycemic
- Language
- ISSN
- 1179-559X
Liraglutide–-a once-daily human glucagon-like peptide-1 receptor agonist for treatment of Type 2 diabetes–-provides effective glycemic control with a lower incidence of hypoglycemia than therapies such as glimepiride and exenatide, and reduces body weight and systolic blood pressure. This article briefly discusses efficacy and safety results from the Liraglutide Effect and Action in Diabetes (LEAD) program, before considering practical issues of identifying and educating patients who may be suitable for liraglutide therapy.